Literature DB >> 12167551

Predicting treatment success at multiple timepoints in diverse patient populations of cocaine-dependent individuals.

Chris Reiber1, Anthony Ramirez, David Parent, Richard A Rawson.   

Abstract

The quest for predictive utility of baseline demographic and drug use characteristics has been difficult. The present article draws data from two studies of cocaine-dependent individuals (N = 297) in treatment at clinics in Los Angeles, and examines the utility of socio-demographic characteristics of patients and in-treatment performance variables as predictors of success at treatment end, 6 and 12 month follow-up assessments. Socio-demographic variables examined are age, gender, ethnicity, and educational attainment; drug use variables include years of cocaine use, self-reported days of cocaine use, the Addiction Severity Index drug composite score, and two composite measures cited in the literature. The in-treatment variables examined include cocaine urine toxicology results, number of weeks retained, and measures of compliance. The self-reported number of days of cocaine use in the past 30 days provides the most predictive utility of all baseline variables evaluated, and is the most parsimonious of the significant variables associated with substance use at all subsequent timepoints. Matching cocaine-dependent patients with treatment types or intensities based on the self-reported number of cocaine use days at intake may increase patient success rates.

Entities:  

Mesh:

Year:  2002        PMID: 12167551     DOI: 10.1016/s0376-8716(02)00103-5

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  14 in total

1.  Using a data science approach to predict cocaine use frequency from depressive symptoms.

Authors:  Robert Suchting; Jessica N Vincent; Scott D Lane; Charles E Green; Joy M Schmitz; Margaret C Wardle
Journal:  Drug Alcohol Depend       Date:  2018-11-15       Impact factor: 4.492

2.  Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients.

Authors:  Frank N Angelo; Michael G McDonell; Michael R Lewin; Debra Srebnik; Jessica Lowe; John Roll; Richard Ries
Journal:  Drug Alcohol Depend       Date:  2012-12-27       Impact factor: 4.492

3.  Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients.

Authors:  Udi E Ghitza; Kenzie L Preston; David H Epstein; Hiroto Kuwabara; Christopher J Endres; Badreddine Bencherif; Susan J Boyd; Marc L Copersino; J James Frost; David A Gorelick
Journal:  Biol Psychiatry       Date:  2010-07-01       Impact factor: 13.382

4.  Hippocampal volume mediates the relationship between measures of pre-treatment cocaine use and within-treatment cocaine abstinence.

Authors:  Jiansong Xu; Hedy Kober; Xin Wang; Elise E DeVito; Kathleen M Carroll; Marc N Potenza
Journal:  Drug Alcohol Depend       Date:  2014-07-17       Impact factor: 4.492

5.  Using addiction severity profiles to differentiate cocaine-dependent patients with and without comorbid major depression.

Authors:  Adam M Leventhal; Marc E Mooney; Katherine A DeLaune; Joy M Schmitz
Journal:  Am J Addict       Date:  2006 Sep-Oct

Review 6.  Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission.

Authors:  Judith A Cook
Journal:  Life Sci       Date:  2011-01-08       Impact factor: 5.037

7.  Variants in GABBR1 Gene Are Associated with Methamphetamine Dependence and Two Years' Relapse after Drug Rehabilitation.

Authors:  Yan Zhao; Sufang Peng; Haifeng Jiang; Jiang Du; Shunying Yu; Min Zhao
Journal:  J Neuroimmune Pharmacol       Date:  2018-08-24       Impact factor: 4.147

8.  Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women.

Authors:  Judith A Cook; Jane K Burke-Miller; Mardge H Cohen; Robert L Cook; David Vlahov; Tracey E Wilson; Elizabeth T Golub; Rebecca M Schwartz; Andrea A Howard; Claudia Ponath; Michael W Plankey; Alexandra M Levine; Andrea Levine; Dennis D Grey
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

9.  Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence.

Authors:  David A Gorelick; Yu Kyeong Kim; Badreddine Bencherif; Susan J Boyd; Richard Nelson; Marc L Copersino; Robert F Dannals; J James Frost
Journal:  Psychopharmacology (Berl)       Date:  2008-09-02       Impact factor: 4.530

10.  Process-of-care measures as predictors of client outcome among a methamphetamine-dependent sample at 12- and 36-month follow-ups.

Authors:  Richard A Rawson; Rachel Gonzales; Lisa Greenwell; Mady Chalk
Journal:  J Psychoactive Drugs       Date:  2012 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.